We think you have liked this presentation. If you wish to download it, please recommend it to your friends in any social system. Share buttons are a little bit lower. Thank you!
Presentation is loading. Please wait.
Published byTatum Eagleton
Modified over 2 years ago
A single dose of erythropoietin in ST-elevation myocardial infarction by Adriaan A. Voors, Anne M.S. Belonje, Felix Zijlstra, Hans L. Hillege, Stefan D. Anker, Riemer H.J.A. Slart, René A. Tio, Arnoud van ‘t Hof, J. Wouter Jukema, Hans Otto J. Peels, José P.S. Henriques, Jurriën M. ten Berg, Jeroen Vos, Wiek H. van Gilst, Dirk J. van Veldhuisen, and EHJ Volume 31(21):2593-2600 November 1, 2010 Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2010. For permissions please email: email@example.com.
Flowchart representing number of patients randomized to erythropoietin or control, and patients who dropped out for provided reasons. Adriaan A. Voors et al. Eur Heart J 2010;31:2593-2600 Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2010. For permissions please email: firstname.lastname@example.org.
Primary endpoint; mean left ventricular ejection fraction (± standard deviation) of patients treated with erythropoietin and of patients in the control group, 6 weeks after a successful primary coronary intervention. Adriaan A. Voors et al. Eur Heart J 2010;31:2593-2600 Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2010. For permissions please email: email@example.com.
Secondary outcome: Kaplan–Meier curves indicating pre-defined cardiovascular events within 6 weeks after a successful primary coronary intervention for a first ST-elevation myocardial infarction in patients treated with a single high dose of erythropoietin or control patients. Adriaan A. Voors et al. Eur Heart J 2010;31:2593-2600 Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2010. For permissions please email: firstname.lastname@example.org.
Dronedarone in patients with congestive heart failure: insights from ATHENA by Stefan H. Hohnloser, Harry J.G.M. Crijns, Martin van Eickels, Christophe.
Reduction in recurrent cardiovascular events with prasugrel compared with clopidogrel in patients with acute coronary syndromes from the TRITON-TIMI 38.
Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty:
An update on regional variation in cardiovascular mortality within Europe by Jacqueline Müller-Nordhorn, Sylvia Binting, Stephanie Roll, and Stefan N.
Short stature is associated with coronary heart disease: a systematic review of the literature and a meta-analysis by Tuula A. Paajanen, Niku K.J. Oksala,
Genous™ endothelial progenitor cell capturing stent vs. the Taxus Liberté stent in patients with de novo coronary lesions with a high-risk of coronary.
Acute viral myocarditis by Robert Dennert, Harry J. Crijns, and Stephane Heymans EHJ Volume 29(17): August 25, 2008 Published on behalf of the.
High spatial resolution myocardial perfusion cardiac magnetic resonance for the detection of coronary artery disease by Sven Plein, Sebastian Kozerke,
The relationship between body mass index, treatment, and mortality in patients with established coronary artery disease: a report from APPROACH by Antigone.
Interventions for prevention of post-operative atrial fibrillation and its complications after cardiac surgery: a meta-analysis by David C. Burgess, Michael.
High heart rate: a cardiovascular risk factor? by Stéphane Cook, Mario Togni, Marcus C. Schaub, Peter Wenaweser, and Otto M. Hess EHJ Volume 27(20):
Imaging and atrial fibrillation: the role of multimodality imaging in patient evaluation and management of atrial fibrillation by Laurens F. Tops, Martin.
Prediction of fatal or near-fatal cardiac arrhythmia events in patients with depressed left ventricular function after an acute myocardial infarction †
Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction by Mortimer Korf-Klingebiel,
Paradoxical low flow and/or low gradient severe aortic stenosis despite preserved left ventricular ejection fraction: implications for diagnosis and treatment.
Dyssynchrony by speckle-tracking echocardiography and response to cardiac resynchronization therapy: results of the Speckle Tracking and Resynchronization.
The combined influence of leisure-time physical activity and weekly alcohol intake on fatal ischaemic heart disease and all-cause mortality by Jane Østergaard.
A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart.
Randomized, non-inferiority trial of three limus agent- eluting stents with different polymer coatings: the Intracoronary Stenting and Angiographic Results:
Five-year echocardiographic results of combined undersized mitral ring annuloplasty and coronary artery bypass grafting for chronic ischaemic mitral regurgitation.
© 2017 SlidePlayer.com Inc. All rights reserved.